Statistics

Total Visits

Views
Maintenance bacillus Calmette-Guerin immunotherapy for TaG3 or T1G3 and/or carcinoma in situ transitional cell carcinoma of the bladder: Final results of the randomized CUETO Group Study 9801388

Select a period of time:

Number of views in the range

Views
Maintenance bacillus Calmette-Guerin immunotherapy for TaG3 or T1G3 and/or carcinoma in situ transitional cell carcinoma of the bladder: Final results of the randomized CUETO Group Study 9801341

Views

Views
December 20255
January 20263
February 20260
March 20269
April 20267
May 202613
June 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States19
Poland4
Bulgaria4
Brazil3
Colombia2
Paraguay2
Argentina2
Germany1
Spain1
Nicaragua1
 

Top cities views

Views
San Jose7
Bogotá2
Miami2
Ashburn2
Brooklyn1
Buffalo1
Caxias do Sul1
Frankfurt am Main1
Los Angeles1
Medrano1